E-Folder - Business

The number and interest to business and corporate scandals grew during the last

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

decade. As soon as loud corporate scandals started to spread all around the worl

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

they became an integral part of business. Scandals in modern world which turn o

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

er the market become more expensive and lead to worse consequences. Everybody ho

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

es that he will be able to avoid scandals but at the same time it is obvious tha

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

no industry is safe from such scandal. The second loudest scandal after Enron w

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s the disintegration of Refco.Inc .

This company was created in 1969 and it bec

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

me popular as a trader of futures, differences, and commodities. Before the bank

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

uptcy in October 2005 it had around 4 billion dollars and operated about 200,000

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

customer accounts and it was officially the largest broker in Chicago. Tradition

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

lly Refco was considered as a reliable company that had constant 33% annual grow

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

h and had confidence of customers.

The results of company sales and rise of sha

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

e prices were amazing and evoked one’s respect and jealousness of competitors. A

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

the time of their collapse the balance sheet numbered $75 billion assets. But t

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

en company share’s prices went down from $28 to $0.8.

The corporate scandal was

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

a reason of such depreciation of company assets which led to persistent bankrupt

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

y. In October, 2005 a public disclosure that the chief executive officer was a r

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ason of crash was made – he had hidden more than $400 million in bad debts form

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

uditors and investors. This was the starting point of Refco’s collapse even thou

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

h it was without a doubt one of the most stationary financial services companies

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/44297/e-folder-Story-of-Refco-Bankruptcy.html">Story of Refco Bankruptcy</a>

BB link (for phorums):
[url=http://www.e-folder.org.ua/article/44297/e-folder-Story-of-Refco-Bankruptcy.html]Story of Refco Bankruptcy[/url]

First Bank of Nigeria Plc on Tuesday began the process of raising fresh funds from the market with an application to the Nigerian Stock Exchange. The bank applied to offer 1.6billion ordinary shares of 50 kobo each to be sold at N33 per share for public subscription and 1.5billion ordinary shares of 50 kobo each at N31 per share as Rights Issue to existing shareholders.

Does your brand evoke an emotional response? Does your brand create loyalty? What would make your clients eager to pay for your products and services? If you want to know how to attract your perfect client through brand marketing online, I'll show you how.

An article about how risk management of sub-contractors and suppliers is vital to a project.

Tags

Links

E-Folder - Story of Refco Bankruptcy

Related Articles: